🇺🇸 FDA
Patent

US 7879801

Compositions comprising cell-impermeant duramycin derivatives

granted A61KA61K2039/505A61K39/395

Quick answer

US patent 7879801 (Compositions comprising cell-impermeant duramycin derivatives) held by The Board of Regents of the University of Texas System expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/505, A61K39/395, A61K39/39558, A61K47/62